Gamma-aminobutyric acid receptor subunit gamma-1 (GABRG1) (GABRG1)

The Gamma-aminobutyric acid receptor subunit gamma-1 (GABRG1) is a protein that forms part of the heteropentameric GABA-A receptor, the primary inhibitory neurotransmitter receptor in the mammalian central nervous system (UniProt: P23901). This subunit contributes to the formation of the benzodiazepine binding site, although it exhibits a distinct pharmacological profile compared to the more prevalent gamma-2 subunit (PubMed: 11511209). GABRG1 is primarily expressed in specific brain regions such as the hypothalamus and amygdala, suggesting a specialized role in regulating emotional states and neuroendocrine functions (NCBI Gene: 2565). Genetic variations in the GABRG1 gene have been linked to alcohol dependence and various anxiety disorders, making it a subject of interest for neuropsychiatric research (PubMed: 16434314). Drugs targeting GABA-A receptors containing this subunit, such as certain benzodiazepines and non-benzodiazepine hypnotics, modulate inhibitory tone by enhancing chloride ion influx upon GABA binding (PubChem: GABRG1). Understanding the specific contributions of the gamma-1 subunit is crucial for developing more selective therapies with reduced side effects like sedation or addiction.

Other names

GABRG1GABA(A) receptor subunit gamma-1Gamma-aminobutyric acid receptor subunit gamma-1GABA receptor subunit gamma-1

Positive allosteric modulation of the GABA-A receptor complex, which increases the frequency of chloride channel opening in response to GABA, leading to neuronal hyperpolarization and reduced excitability.